drug · small molecule
vodobatinib
Phase 2updated 3mo agoby Sun Pharma Advanced Research Company Ltd🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Phase 2 (across all indications), with 4 investigational indications.
targets
Tyrosine-protein kinase ABL1Bcr/Abl fusion protein
all catalysts(0)
nothing on the calendar yet
Trials studying vodobatinib
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 41m ago
Found something off?
comments(0)
5-min edit window · permanent after that